CLAIRE THOMPSON: Open Payments
NPI 1366201162 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 18 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $297 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $257 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $85 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: FASENRA, AIRSUPRA, DUPIXENT, NEFFY, VRAYLAR, MOUNJARO, AREXVY, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
